{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["acacetin", "bioavailability", "gastrointestinal absorption", "solubility", "stability", "tissue metabolism"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33525442", "DateRevised": {"Year": "2021", "Month": "03", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "01", "Day": "28"}], "Language": ["eng"], "ELocationID": ["175", "10.3390/pharmaceutics13020175"], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "13", "Issue": "2", "PubDate": {"Year": "2021", "Month": "Jan", "Day": "28"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "Investigation of the Factors Responsible for the Poor Oral Bioavailability of Acacetin in Rats: Physicochemical and Biopharmaceutical Aspects.", "Abstract": {"AbstractText": ["Acacetin, an important ingredient of acacia honey and a component of several medicinal plants, exhibits therapeutic effects such as antioxidative, anticancer, anti-inflammatory, and anti-plasmodial activities. However, to date, studies reporting a systematic investigation of the in vivo fate of orally administered acacetin are limited. Moreover, the in vitro physicochemical and biopharmaceutical properties of acacetin in the gastrointestinal (GI) tract and their pharmacokinetic impacts remain unclear. Therefore, in this study, we aimed to systematically investigate the oral absorption and disposition of acacetin using relevant rat models. Acacetin exhibited poor solubility (\u2264119 ng/mL) and relatively low stability (27.5-62.0% remaining after 24 h) in pH 7 phosphate buffer and simulated GI fluids. A major portion (97.1%) of the initially injected acacetin dose remained unabsorbed in the jejunal segments, and the oral bioavailability of acacetin was very low at 2.34%. The systemic metabolism of acacetin occurred ubiquitously in various tissues (particularly in the liver, where it occurred most extensively), resulting in very high total plasma clearance of 199 \u00b1 36 mL/min/kg. Collectively, the poor oral bioavailability of acacetin could be attributed mainly to its poor solubility and low GI luminal stability."]}, "AuthorList": [{"Identifier": ["0000-0002-1180-2864"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Han", "ForeName": "Dong-Gyun", "Initials": "DG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Korea."}], "LastName": "Cha", "ForeName": "Eunju", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Korea."}], "LastName": "Joo", "ForeName": "Jeongmin", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Korea."}], "LastName": "Hwang", "ForeName": "Ji Sun", "Initials": "JS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Korea."}], "LastName": "Kim", "ForeName": "Sanghyun", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Korea."}], "LastName": "Park", "ForeName": "Taeuk", "Initials": "T"}, {"Identifier": ["0000-0002-4190-6525"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Korea."}], "LastName": "Jeong", "ForeName": "Yoo-Seong", "Initials": "YS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, College of Pharmacy, Gachon University, Incheon 21936, Korea."}], "LastName": "Maeng", "ForeName": "Han-Joo", "Initials": "HJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Korea."}], "LastName": "Kim", "ForeName": "Sang-Bum", "Initials": "SB"}, {"Identifier": ["0000-0002-0997-5723"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Yoon", "ForeName": "In-Soo", "Initials": "IS"}], "GrantList": [{"GrantID": "NRF-2020R1C1C1011061", "Agency": "National Research Foundation of Korea", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors report no conflict of interest in this work."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Kim S.B., Lee T., Lee H.S., Song C.K., Cho H.J., Kim D.D., Maeng H.J., Yoon I.S. Development and validation of a highly sensitive LC-MS/MS method for the determination of acacetin in human plasma and its application to a protein binding study. Arch. Pharm. Res. 2016;39:213\u2013220. doi: 10.1007/s12272-015-0697-1.", "ArticleIdList": ["10.1007/s12272-015-0697-1", "26677081"]}, {"Citation": "Fan L.H., Li X., Chen D.Y., Zhang N., Wang Y., Shan Y., Hu Y., Xu R.A., Jin J., Ge R.S. Determination of acacetin in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study. J. Chromatogr. B. 2015;986\u2013987:18\u201322. doi: 10.1016/j.jchromb.2015.01.040.", "ArticleIdList": ["10.1016/j.jchromb.2015.01.040", "25703948"]}, {"Citation": "Jeong E.H., Yang H., Kim J.E., Lee K.W. Safflower seed oil and its active compound acacetin inhibit UVB-induced skin photoaging. J. Microbiol. Biotechnol. 2020 doi: 10.4014/jmb.2003.03064.", "ArticleIdList": ["10.4014/jmb.2003.03064", "32522955"]}, {"Citation": "Jung S.K., Kim J.E., Lee S.Y., Lee M.H., Byun S., Kim Y.A., Lim T.G., Reddy K., Huang Z., Bode A.M., et al. The P110 subunit of PI3-K is a therapeutic target of acacetin in skin cancer. Carcinogenesis. 2014;35:123\u2013130. doi: 10.1093/carcin/bgt266.", "ArticleIdList": ["10.1093/carcin/bgt266", "PMC3895936", "23913940"]}, {"Citation": "Kim H.R., Park C.G., Jung J.Y. Acacetin (5,7-dihydroxy-4\u2032-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-kappaB/Akt signaling in prostate cancer cells. Int. J. Mol. Med. 2014;33:317\u2013324. doi: 10.3892/ijmm.2013.1571.", "ArticleIdList": ["10.3892/ijmm.2013.1571", "24285354"]}, {"Citation": "Chien S.T., Lin S.S., Wang C.K., Lee Y.B., Chen K.S., Fong Y., Shih Y.W. Acacetin inhibits the invasion and migration of human non-small cell lung cancer A549 cells by suppressing the p38alpha MAPK signaling pathway. Mol. Cell Biochem. 2011;350:135\u2013148. doi: 10.1007/s11010-010-0692-2.", "ArticleIdList": ["10.1007/s11010-010-0692-2", "21210297"]}, {"Citation": "Shim H.Y., Park J.H., Paik H.D., Nah S.Y., Kim D.S., Han Y.S. Acacetin-induced apoptosis of human breast cancer MCF-7 cells involves caspase cascade, mitochondria-mediated death signaling and SAPK/JNK1/2-c-Jun activation. Mol. Cells. 2007;24:95\u2013104.", "ArticleIdList": ["17846503"]}, {"Citation": "Zhang Q., Zhu L., Gong X., Ruan Y., Yu J., Jiang H., Wang Y., Qi X., Lu L., Liu Z. Sulfonation disposition of acacetin: In vitro and in vivo. J. Agric. Food Chem. 2017;65:4921\u20134931. doi: 10.1021/acs.jafc.7b00854.", "ArticleIdList": ["10.1021/acs.jafc.7b00854", "28540728"]}, {"Citation": "Moniruzzaman M., Sulaiman S.A., Azlan S.A., Gan S.H. Two-year variations of phenolics, flavonoids and antioxidant contents in acacia honey. Molecules. 2013;18:14694\u201314710. doi: 10.3390/molecules181214694.", "ArticleIdList": ["10.3390/molecules181214694", "PMC6270151", "24287998"]}, {"Citation": "Muhammad A., Odunola O.A., Ibrahim M.A., Sallau A.B., Erukainure O.L., Aimola I.A., Malami I. Potential biological activity of acacia honey. Front. Biosci. 2016;8:351\u2013357. doi: 10.2741/e771.", "ArticleIdList": ["10.2741/e771", "26709666"]}, {"Citation": "Meo S.A., Al-Asiri S.A., Mahesar A.L., Ansari M.J. Role of honey in modern medicine. Saudi J. Biol. Sci. 2017;24:975\u2013978. doi: 10.1016/j.sjbs.2016.12.010.", "ArticleIdList": ["10.1016/j.sjbs.2016.12.010", "PMC5478293", "28663690"]}, {"Citation": "Thilakarathna S.H., Rupasinghe H.P. Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients. 2013;5:3367\u20133387. doi: 10.3390/nu5093367.", "ArticleIdList": ["10.3390/nu5093367", "PMC3798909", "23989753"]}, {"Citation": "Cho H.J., Kim J.E., Kim D.D., Yoon I.S. In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: Principles and applications. Drug Dev. Ind. Pharm. 2014;40:989\u2013998. doi: 10.3109/03639045.2013.831439.", "ArticleIdList": ["10.3109/03639045.2013.831439", "23981203"]}, {"Citation": "Li J., Yang Y., Ning E., Peng Y., Zhang J. Mechanisms of poor oral bioavailability of flavonoid morin in rats: From physicochemical to biopharmaceutical evaluations. Eur. J. Pharm. Sci. 2019;128:290\u2013298. doi: 10.1016/j.ejps.2018.12.011.", "ArticleIdList": ["10.1016/j.ejps.2018.12.011", "30557605"]}, {"Citation": "Kim J.E., Cho H.J., Kim J.S., Shim C.K., Chung S.J., Oak M.H., Yoon I.S., Kim D.D. The limited intestinal absorption via paracellular pathway is responsible for the low oral bioavailability of doxorubicin. Xenobiotica. 2013;43:579\u2013591. doi: 10.3109/00498254.2012.751140.", "ArticleIdList": ["10.3109/00498254.2012.751140", "23252722"]}, {"Citation": "Kim J.E., Yoon I.S., Cho H.J., Kim D.H., Choi Y.H., Kim D.D. Emulsion-based colloidal nanosystems for oral delivery of doxorubicin: Improved intestinal paracellular absorption and alleviated cardiotoxicity. Int. J. Pharm. 2014;464:117\u2013126. doi: 10.1016/j.ijpharm.2014.01.016.", "ArticleIdList": ["10.1016/j.ijpharm.2014.01.016", "24463005"]}, {"Citation": "Davidson M.H., Lukacsko P., Sun J.X., Phillips G., Walters E., Sterman A., Niecestro R., Friedhoff L. A multiple-dose pharmacodynamic, safety, and pharmacokinetic comparison of extended- and immediate-release formulations of lovastatin. Clin. Ther. 2002;24:112\u2013125. doi: 10.1016/S0149-2918(02)85009-3.", "ArticleIdList": ["10.1016/S0149-2918(02)85009-3", "11833826"]}, {"Citation": "Yanamandra S., Venkatesan N., Kadajji V.G., Wang Z., Issar M., Betageri G.V. Proliposomes as a drug delivery system to decrease the hepatic first-pass metabolism: Case study using a model drug. Eur. J. Pharm. Sci. 2014;64:26\u201336. doi: 10.1016/j.ejps.2014.08.008.", "ArticleIdList": ["10.1016/j.ejps.2014.08.008", "25159836"]}, {"Citation": "Yin J., Ma Y., Liang C., Gao J., Wang H., Zhang L. A systematic study of the metabolites of dietary acacetin in vivo and in vitro based on UHPLC-Q-TOF-MS/MS analysis. J. Agric. Food Chem. 2019;67:5530\u20135543. doi: 10.1021/acs.jafc.9b00330.", "ArticleIdList": ["10.1021/acs.jafc.9b00330", "31025561"]}, {"Citation": "Hodek P., Trefil P., Stiborova M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem. Biol. Interact. 2002;139:1\u201321. doi: 10.1016/S0009-2797(01)00285-X.", "ArticleIdList": ["10.1016/S0009-2797(01)00285-X", "11803026"]}, {"Citation": "Dai P., Luo F., Wang Y., Jiang H., Wang L., Zhang G., Zhu L., Hu M., Wang X., Lu L., et al. Species- and gender-dependent differences in the glucuronidation of a flavonoid glucoside and its aglycone determined using expressed UGT enzymes and microsomes. Biopharm. Drug Dispos. 2015;36:622\u2013635. doi: 10.1002/bdd.1989.", "ArticleIdList": ["10.1002/bdd.1989", "26317684"]}, {"Citation": "Han D.G., Kim K.S., Seo S.W., Baek Y.M., Jung Y., Kim D.D., Yoon I.S. A sensitive HPLC-FL method to simultaneously determine febuxostat and diclofenac in rat plasma: Assessment of metabolic drug interactions in vitro and in vivo. Anal. Methods. 2020;12:2166\u20132175. doi: 10.1039/D0AY00471E.", "ArticleIdList": ["10.1039/D0AY00471E"]}, {"Citation": "USA Food and Drug Administration  Guidance for Industry: Bioanalytical Method Validation.  [(accessed on 28 November 2019)];2018  Available online:  https://www.fda.gov/media/70858/download."}, {"Citation": "Jang J.H., Jeong S.H., Cho H.Y., Lee Y.B. Comparison of UPLC-MS/MS and HPLC-UV methods for the determination of zaltoprofen in human plasma. J. Pharm. Investig. 2019;49:613\u2013624. doi: 10.1007/s40005-018-00416-w.", "ArticleIdList": ["10.1007/s40005-018-00416-w"]}, {"Citation": "Seo S.W., Park J.W., Han D.G., Kim J.M., Kim S., Park T., Kang K.H., Yang M.H., Yoon I.S. In vitro and in vivo assessment of metabolic drug interaction potential of dutasteride with ketoconazole. Pharmaceutics. 2019;11:673. doi: 10.3390/pharmaceutics11120673.", "ArticleIdList": ["10.3390/pharmaceutics11120673", "PMC6956158", "31835695"]}, {"Citation": "Kim S.B., Kim K.S., Ryu H.M., Yoon I.S., Cho H.J., Chung S.J., Chong S., Kim D.D. Comparison of saline vs. blood replenishment after blood sampling in a rat pharmacokinetic study. J. Pharm. Investig. 2019;49:543\u2013551. doi: 10.1007/s40005-018-00420-0.", "ArticleIdList": ["10.1007/s40005-018-00420-0"]}, {"Citation": "Jeong S.H., Jang J.H., Cho H.Y., Oh I.J., Lee Y.B. A sensitive UPLC\u2013ESI\u2013MS/MS method for the quantification of cinnamic acid in vivo and in vitro: Application to pharmacokinetic and protein binding study in human plasma. J. Pharm. Investig. 2020;50:159\u2013172. doi: 10.1007/s40005-019-00444-0.", "ArticleIdList": ["10.1007/s40005-019-00444-0"]}, {"Citation": "Kiani Y.S., Jabeen I. Lipophilic metabolic efficiency (LipMetE) and drug efficiency indices to explore the metabolic properties of the substrates of selected cytochrome P450 isoforms. ACS Omega. 2020;5:179\u2013188. doi: 10.1021/acsomega.9b02344.", "ArticleIdList": ["10.1021/acsomega.9b02344", "PMC6963890", "31956764"]}, {"Citation": "Hughes J.D., Blagg J., Price D.A., Bailey S., Decrescenzo G.A., Devraj R.V., Ellsworth E., Fobian Y.M., Gibbs M.E., Gilles R.W., et al. Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorg. Med. Chem. Lett. 2008;18:4872\u20134875. doi: 10.1016/j.bmcl.2008.07.071.", "ArticleIdList": ["10.1016/j.bmcl.2008.07.071", "18691886"]}, {"Citation": "Lang C.C., Moreland T.A., Davey P.G. Bioavailability of cefuroxime axetil: Comparison of standard and abbreviated methods. J. Antimicrob. Chemother. 1990;25:645\u2013650. doi: 10.1093/jac/25.4.645.", "ArticleIdList": ["10.1093/jac/25.4.645", "2351625"]}, {"Citation": "Nayak B.S., Roy H., Dinda S.C., Ellaiah P. Pharmacokinetic evaluation of flavonoid compound (acacetin) isolated from Gmelina arborea roxb. Res. J. Pharm. Technol. 2019;12:3659\u20133663. doi: 10.5958/0974-360X.2019.00624.3.", "ArticleIdList": ["10.5958/0974-360X.2019.00624.3"]}, {"Citation": "Jiang H., Yu J., Zheng H., Chen J., Wu J., Qi X., Wang Y., Wang X., Hu M., Zhu L., et al. Breast cancer resistance protein and multidrug resistance protein 2 regulate the disposition of acacetin glucuronides. Pharm. Res. 2017;34:1402\u20131415. doi: 10.1007/s11095-017-2157-8.", "ArticleIdList": ["10.1007/s11095-017-2157-8", "28421306"]}, {"Citation": "Zhang Z., Jia P., Zhang X., Zhang Q., Yang H., Shi H., Zhang L. LC-MS/MS determination and pharmacokinetic study of seven flavonoids in rat plasma after oral administration of Cirsium japonicum DC. extract. J. Ethnopharmacol. 2014;158:66\u201375. doi: 10.1016/j.jep.2014.10.022.", "ArticleIdList": ["10.1016/j.jep.2014.10.022", "25456423"]}, {"Citation": "Fagerholm U. Prediction of human pharmacokinetics-gastrointestinal absorption. J. Pharm. Pharmacol. 2007;59:905\u2013916. doi: 10.1211/jpp.59.7.0001.", "ArticleIdList": ["10.1211/jpp.59.7.0001", "17637184"]}, {"Citation": "Hilgers A.R., Smith D.P., Biermacher J.J., Day J.S., Jensen J.L., Sims S.M., Adams W.J., Friis J.M., Palandra J., Hosley J.D., et al. Predicting oral absorption of drugs: A case study with a novel class of antimicrobial agents. Pharm. Res. 2003;20:1149\u20131155. doi: 10.1023/A:1025084527878.", "ArticleIdList": ["10.1023/A:1025084527878", "12948011"]}, {"Citation": "Li L., Zhao Y., Du F., Yang J., Xu F., Niu W., Ren Y., Li C. Intestinal absorption and presystemic elimination of various chemical constituents present in GBE50 extract, a standardized extract of Ginkgo biloba leaves. Curr. Drug Metab. 2012;13:494\u2013509. doi: 10.2174/1389200211209050494.", "ArticleIdList": ["10.2174/1389200211209050494", "22292790"]}, {"Citation": "Cho H.J., Park J.W., Yoon I.S., Kim D.D. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: Enhanced intestinal absorption and lymphatic uptake. Int. J. Nanomed. 2014;9:495\u2013504.", "ArticleIdList": ["PMC3894956", "24531717"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "9"}, {"Year": "2021", "Month": "1", "Day": "24"}, {"Year": "2021", "Month": "1", "Day": "25"}, {"Year": "2021", "Month": "2", "Day": "2", "Hour": "1", "Minute": "3"}, {"Year": "2021", "Month": "2", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "3", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "1", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["33525442", "PMC7911516", "10.3390/pharmaceutics13020175", "pharmaceutics13020175"]}}], "PubmedBookArticle": []}